Literature DB >> 12475924

Grand ideas floating freely. Conference on the new prion biology: basic science, diagnosis and therapy.

Bruce Chesebro1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12475924      PMCID： PMC1308306          DOI： 10.1093/embo-reports/kvf256

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  17 in total

1.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

Authors:  G P Saborio; B Permanne; C Soto
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

Review 2.  Studies on peptide fragments of prion proteins.

Authors:  F Tagliavini; G Forloni; P D'Ursi; O Bugiani; M Salmona
Journal:  Adv Protein Chem       Date:  2001

3.  Crystal structure of the human prion protein reveals a mechanism for oligomerization.

Authors:  K J Knaus; M Morillas; W Swietnicki; M Malone; W K Surewicz; V C Yee
Journal:  Nat Struct Biol       Date:  2001-09

4.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.

Authors:  J D Wadsworth; S Joiner; A F Hill; T A Campbell; M Desbruslais; P J Luthert; J Collinge
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

5.  A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy.

Authors:  J C Manson; E Jamieson; H Baybutt; N L Tuzi; R Barron; I McConnell; R Somerville; J Ironside; R Will; M S Sy; D W Melton; J Hope; C Bostock
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

6.  Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers.

Authors:  R M Barron; V Thomson; E Jamieson; D W Melton; J Ironside; R Will; J C Manson
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

7.  Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.

Authors:  F L Heppner; C Musahl; I Arrighi; M A Klein; T Rülicke; B Oesch; R M Zinkernagel; U Kalinke; A Aguzzi
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

8.  A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases.

Authors:  G M Shaked; Y Shaked; Z Kariv-Inbal; M Halimi; I Avraham; R Gabizon
Journal:  J Biol Chem       Date:  2001-06-21       Impact factor: 5.157

9.  Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein. Expression in testis and ectopic production in the brains of Prnp(0/0) mice predisposed to Purkinje cell loss.

Authors:  G L Silverman; K Qin; R C Moore; Y Yang; P Mastrangelo; P Tremblay; S B Prusiner; F E Cohen; D Westaway
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

10.  Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel.

Authors:  R C Moore; I Y Lee; G L Silverman; P M Harrison; R Strome; C Heinrich; A Karunaratne; S H Pasternak; M A Chishti; Y Liang; P Mastrangelo; K Wang; A F Smit; S Katamine; G A Carlson; F E Cohen; S B Prusiner; D W Melton; P Tremblay; L E Hood; D Westaway
Journal:  J Mol Biol       Date:  1999-10-01       Impact factor: 5.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.